BioHarvest Sciences CEO Ilan Sobel and Chairman Dr. Zaki Rakib joined Steve Darling from Proactive to share the company has announced its upcoming debut on the Nasdaq exchange, with trading scheduled to commence on November 12, under the symbol “BHST.” Currently listed on the OTCQB and Canadian Securities Exchange, BioHarvest will complete its OTCQB trading by the close of November 11 before making its transition to Nasdaq.
CEO Ilan Sobel and Chairman Dr. Zaki Rakib highlighted the importance of this listing in enhancing the company's profile and shareholder value. Dr. Rakib described the Nasdaq debut as a pivotal milestone for the company’s growth trajectory. BioHarvest Sciences specializes in botanical synthesis, utilizing a patented technology to produce active plant ingredients without cultivating the entire plant. This innovative approach positions BioHarvest to capture new market opportunities and provide consistent, sustainable solutions in the health and wellness sectors.
The move aims to increase visibility, attract institutional investors, and lay the groundwork for future growth.